Poncin S et al. |
N-acetylcysteine and 15 deoxy-{delta}12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1{alpha}/interferon {gamma}-induced inhibitory effects in thyrocytes in vitro. |
2010 |
Am. J. Pathol. |
pmid:20489149
|
Diers AR et al. |
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. |
2010 |
Biochem. J. |
pmid:20536428
|
Pedersen PJ et al. |
Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties. |
2010 |
Bioorg. Med. Chem. Lett. |
pmid:20591667
|
Reddy RC and Standiford TJ |
Nrf2 and PPAR{gamma}: PPARtnering against oxidant-induced lung injury. |
2010 |
Am. J. Respir. Crit. Care Med. |
pmid:20634499
|
Kar R et al. |
Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1. |
2010 |
Biochem. Biophys. Res. Commun. |
pmid:20678484
|
Syed MA et al. |
Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages. |
2010 |
Exp. Cell Res. |
pmid:20797396
|
Li H et al. |
Serum amyloid A activates peroxisome proliferator-activated receptor γ through extracellularly regulated kinase 1/2 and COX-2 expression in hepatocytes. |
2010 |
Biochemistry |
pmid:20853849
|
Tang FT et al. |
Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression. |
2011 |
Eur. J. Pharmacol. |
pmid:20854809
|
Bräutigam K et al. |
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. |
2011 |
J. Cancer Res. Clin. Oncol. |
pmid:20878528
|
Alves C et al. |
Effects of 15d-PGJâ‚‚-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. |
2011 |
Br. J. Pharmacol. |
pmid:20883476
|
Kim NJ et al. |
Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). |
2010 |
J. Org. Chem. |
pmid:20929274
|
Liu H et al. |
Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. |
2011 |
Neurobiol. Dis. |
pmid:20933087
|
Hardy KD et al. |
Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. |
2011 |
J. Lipid Res. |
pmid:20944061
|
Lotz C et al. |
Peroxisome-proliferator-activated receptor γ mediates the second window of anaesthetic-induced preconditioning. |
2011 |
Exp. Physiol. |
pmid:21123361
|
Tsujita T et al. |
Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish. |
2011 |
Genes Cells |
pmid:21143560
|
Neri T et al. |
Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles. |
2011 |
Eur. Respir. J. |
pmid:21148223
|
Charles RL et al. |
Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. |
2011 |
Circ. Res. |
pmid:21164107
|
Li N et al. |
Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. |
2011 |
J. Cell. Biochem. |
pmid:21268089
|
MartÃnez-Gras I et al. |
The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. |
2011 |
Schizophr. Res. |
pmid:21334179
|
Chbicheb S et al. |
EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. |
2011 |
Biochem. Pharmacol. |
pmid:21338579
|
Lin TH et al. |
15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. |
2011 |
J. Cell. Physiol. |
pmid:21344384
|
Gijsbers L et al. |
Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression. |
2011 |
Anal. Biochem. |
pmid:21354099
|
Maekawa N et al. |
High-performance affinity purification for identification of 15-deoxy-Δ 12,14 -PGJ₂ interacting factors using magnetic nanobeads. |
2011 |
Biomed. Chromatogr. |
pmid:21374648
|
Kane CJ et al. |
Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists. |
2011 |
Brain Behav. Immun. |
pmid:21376806
|
Wang JJ and Mak OT |
Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21396480
|
Yamamoto Y et al. |
Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane. |
2011 |
PLoS ONE |
pmid:21445266
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Raman P et al. |
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. |
2011 |
Mol. Pharmacol. |
pmid:21511917
|
Shao Z et al. |
Choroidal involution is a key component of oxygen-induced retinopathy. |
2011 |
Invest. Ophthalmol. Vis. Sci. |
pmid:21546530
|
Gandhi UH et al. |
Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. |
2011 |
J. Biol. Chem. |
pmid:21669866
|
Cha B et al. |
15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. |
2011 |
J. Physiol. Pharmacol. |
pmid:21673364
|
Ulivi V et al. |
Anti-inflammatory activity of monogalactosyldiacylglycerol in human articular cartilage in vitro: activation of an anti-inflammatory cyclooxygenase-2 (COX-2) pathway. |
2011 |
Arthritis Res. Ther. |
pmid:21682897
|
Yamamoto Y et al. |
15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. |
2011 |
Biochem. Biophys. Res. Commun. |
pmid:21683069
|
Tobiasova Z et al. |
Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells. |
2011 |
Circulation |
pmid:21690493
|
Chowdhury AA et al. |
15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21699992
|
Song NY et al. |
Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells. |
2011 |
Chem. Res. Toxicol. |
pmid:21728338
|
Bardelli C et al. |
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. |
2012 |
Br. J. Pharmacol. |
pmid:21745193
|
Surh YJ et al. |
15-Deoxy-Δ¹²,¹â´-prostaglandin Jâ‚‚, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling. |
2011 |
Biochem. Pharmacol. |
pmid:21843512
|
Miyawaki T et al. |
Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells. |
2012 |
Immunopharmacol Immunotoxicol |
pmid:21854184
|
Leamy AW et al. |
Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. |
2011 |
Neurosci. Lett. |
pmid:21855605
|
Tanaka A et al. |
Mast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2. |
2011 |
Am. J. Physiol., Cell Physiol. |
pmid:21865589
|
Tao H and Hajri T |
Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists. |
2011 |
Biochem. Pharmacol. |
pmid:21924248
|
De Nuccio C et al. |
Peroxisome proliferator-activated receptor γ agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. |
2011 |
J. Neuropathol. Exp. Neurol. |
pmid:21937914
|
de Jong E et al. |
Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC. |
2011 |
PLoS ONE |
pmid:21957481
|
Wang JJ and Mak OT |
Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGDâ‚‚ metabolite, 15d-PGJâ‚‚. |
2011 |
Cell Biol. Int. |
pmid:21999315
|
Seno T et al. |
15-Deoxy-Δ¹²,¹ⴠprostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice. |
2011 |
PLoS ONE |
pmid:22003398
|
He S et al. |
Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella). |
2012 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:22079418
|
Wang P et al. |
Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. |
2011 |
PLoS ONE |
pmid:22096605
|
Hossain MS et al. |
Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids. |
2012 |
Exp. Cell Res. |
pmid:22100987
|
Murata T et al. |
Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. |
2011 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:22106279
|